Maricopa County Special Health Care District

Maricopa County Special Health Care District was paid $251.46M by Medicaid between Jan 2018 and Dec 2024, across 723 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoMARICOPA COUNTY SPECIAL HEALTH CARE DISTRICT
PHOENIX, AZ 85008

33aNPI1073576740assigned 04/11/2006

33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center

28Total paid$251.46M

24GClaims4,606,950

24DCodes billed723

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Arizona

Rank by total paid#1 of 129

Median peer was paid$2.64M

This provider vs. median95×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	564,776	$30.48M
2019	674,219	$37.79M
2020	567,765	$30.50M
2021	669,225	$35.01M
2022	746,189	$39.82M
2023	770,231	$42.93M
2024incomplete	614,545	$34.93M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	18%	131,735	123,270	$45.60M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	12%	49,116	45,181	$29.87M
74177	Computed tomography, abdomen and pelvis; with contrast material	12%	29,526	28,163	$29.41M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.1%	48,941	46,423	$23.00M
99282	Emergency department visit for the evaluation and management, low to moderate severity	7.4%	89,820	85,313	$18.59M
70450	Computed tomography, head or brain; without contrast material	4.3%	26,651	24,906	$10.74M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	3,283	3,194	$3.98M
72125	Computed tomography, cervical spine; without contrast material	1.6%	8,761	8,299	$3.93M
93975		1.5%	12,512	11,913	$3.69M
T1015	A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive	1.4%	14,304	10,326	$3.56M
G0378	Hospital observation service, per hour	1.4%	37,065	17,592	$3.51M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	7,853	7,566	$3.09M

711 more codes

97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.1%	40,468	$2.87M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	3,728	$2.66M
44970		1.0%	394	$2.61M
T1016	Case management, each 15 minutes	<1%	24,778	$2.15M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	15,376	$2.15M
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,964	$2.11M
80053	Comprehensive metabolic panel	<1%	192,044	$2.02M
99214	Doctor's office visit, returning patient (more involved)	<1%	114,299	$1.95M
16020		<1%	13,543	$1.82M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,346	$1.77M
99213	Doctor's office visit, returning patient (routine)	<1%	126,215	$1.72M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,610	$1.61M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,699	$1.55M
47562		<1%	218	$1.47M
92587		<1%	2,954	$1.41M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	98,703	$1.24M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	663	$1.08M
74174		<1%	879	$1.05M
20610		<1%	3,370	$1.00M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	23,706	$946K
72131		<1%	4,615	$935K
12001		<1%	2,517	$899K
70498		<1%	2,344	$869K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	11,736	$818K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	16,384	$766K
94060		<1%	2,145	$761K
93970		<1%	3,519	$754K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,750	$723K
93976		<1%	16,635	$718K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	535	$675K
73110		<1%	8,053	$671K
70491		<1%	1,275	$619K
99215	Doctor's office visit, returning patient (complex)	<1%	19,592	$596K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,296	$568K
76642		<1%	4,490	$565K
12002		<1%	1,817	$555K
73130		<1%	10,912	$541K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	4,507	$536K
87536		<1%	5,495	$517K
73630		<1%	11,959	$516K
72141		<1%	1,082	$511K
73610		<1%	8,999	$484K
71046	Radiologic examination, chest; 2 views	<1%	50,402	$484K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	849	$465K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	107,759	$456K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	438	$447K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,625	$443K
12011		<1%	1,727	$439K
10060		<1%	2,405	$439K
67028	Intravitreal injection of a pharmacologic agent	<1%	1,856	$435K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	17,415	$401K
20611		<1%	2,018	$394K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	10,738	$384K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	30,591	$380K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,006	$377K
29125		<1%	1,427	$364K
76830	Ultrasound, transvaginal	<1%	8,832	$342K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	2,852	$341K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,383	$336K
74183		<1%	721	$319K
H0031	Mental health assessment, by non-physician	<1%	619	$315K
92557		<1%	3,352	$315K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	2,216	$299K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,702	$297K
76536		<1%	2,846	$297K
80074		<1%	5,452	$287K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,438	$285K
97602		<1%	2,155	$280K
96375	Therapeutic injection; each additional sequential IV push	<1%	54,001	$277K
94010		<1%	1,480	$274K
73030		<1%	8,066	$257K
97165		<1%	11,103	$255K
73564		<1%	2,217	$250K
73080		<1%	4,090	$247K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	15,762	$243K
73700		<1%	785	$242K
76770		<1%	2,756	$240K
97597		<1%	1,679	$235K
73562		<1%	9,111	$235K
73140		<1%	4,364	$230K
71250		<1%	2,157	$229K
80048	Basic metabolic panel (calcium, ionized)	<1%	33,959	$226K
H0038	Self-help/peer services, per 15 minutes	<1%	1,870	$223K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	146	$215K
70486		<1%	3,952	$185K
H2014	Skills training and development, per 15 minutes	<1%	852	$183K
93971		<1%	4,597	$181K
H2027	Psychoeducational service, per 15 minutes	<1%	1,142	$179K
94726		<1%	1,441	$169K
73590		<1%	4,837	$169K
92083		<1%	1,654	$168K
99464		<1%	3,000	$168K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	15,419	$149K
76882		<1%	3,078	$142K
73090		<1%	4,233	$141K
19083		<1%	111	$139K
77080		<1%	1,710	$139K
93226		<1%	713	$138K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,226	$137K
72100		<1%	2,302	$130K
C1769	Guide wire	<1%	1,213	$127K
29515		<1%	515	$125K
73560		<1%	2,372	$118K
J2778	Injection, ranibizumab, 0.1 mg	<1%	108	$118K
86480		<1%	4,374	$117K
97161		<1%	9,893	$116K
81599		<1%	771	$113K
74018		<1%	4,894	$112K
86003		<1%	763	$109K
77066	Tomosynthesis, mammo	<1%	2,814	$106K
92250		<1%	1,281	$106K
84443	Thyroid stimulating hormone (TSH)	<1%	31,221	$105K
87522	Neg quan hep c or qual rna	<1%	3,396	$104K
73221		<1%	462	$102K
11721		<1%	2,788	$102K
70496		<1%	2,078	$100K
87902		<1%	212	$98K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	193,625	$97K
71271		<1%	1,170	$92K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	399	$92K
16025		<1%	584	$89K
72110		<1%	955	$88K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	72,622	$85K
70487		<1%	156	$83K
73502		<1%	3,687	$78K
74220		<1%	395	$77K
93017		<1%	1,325	$75K
80061	Lipid panel	<1%	33,657	$74K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,395	$73K
73701		<1%	110	$72K
97168		<1%	1,924	$69K
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	41	$68K
59025	Fetal non-stress test	<1%	3,162	$68K
11055		<1%	506	$64K
74160		<1%	195	$64K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,932	$64K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	552	$63K
73552		<1%	2,166	$63K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	47,213	$61K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	10,563	$60K
73070		<1%	895	$58K
72050		<1%	372	$58K
95908		<1%	177	$57K
73060		<1%	1,885	$56K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	629	$55K
77065	Tomosynthesis, mammo	<1%	2,302	$54K
99203	Doctor's office visit, new patient (routine)	<1%	2,665	$49K
87507		<1%	528	$49K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,797	$49K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	8,658	$48K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	31,258	$48K
11056		<1%	442	$47K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	66	$46K
97760		<1%	4,833	$45K
80076		<1%	2,576	$44K
36430		<1%	952	$44K
74230		<1%	270	$44K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,743	$44K
99204	Doctor's office visit, new patient (more involved)	<1%	1,935	$41K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	14,371	$41K
93308		<1%	1,188	$39K
72128		<1%	3,565	$39K
82274		<1%	7,324	$37K
11100		<1%	108	$36K
A6198	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing	<1%	3,358	$35K
92228		<1%	937	$35K
76775		<1%	700	$33K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	513	$32K
96361	Intravenous infusion, hydration; each additional hour	<1%	73,534	$31K
T1002	Rn services, up to 15 minutes	<1%	3,914	$31K
72040		<1%	770	$31K
71045	Radiologic examination, chest; single view	<1%	27,849	$30K
73000		<1%	454	$30K
92136		<1%	317	$29K
86235		<1%	745	$29K
72114		<1%	264	$28K
90677		<1%	579	$28K
84702		<1%	10,429	$27K
76801		<1%	4,516	$27K
80320		<1%	22,835	$26K
76942		<1%	262	$26K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	51,984	$25K
84403		<1%	1,471	$25K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	22,246	$25K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	1,366	$25K
96367		<1%	3,234	$23K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,245	$22K
82746		<1%	3,714	$22K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	42	$22K
93923		<1%	312	$22K
51702		<1%	1,769	$22K
90670		<1%	1,652	$21K
81513		<1%	306	$20K
29075		<1%	165	$20K
16030		<1%	50	$20K
90746		<1%	417	$20K
J1756	Injection, iron sucrose, 1 mg	<1%	665	$19K
95819		<1%	82	$19K
29065		<1%	616	$19K
92579		<1%	642	$18K
86803		<1%	16,397	$18K
87631		<1%	6,824	$18K
74019		<1%	1,806	$17K
12013		<1%	76	$17K
H0004	Behavioral health counseling and therapy, per 15 minutes	<1%	126	$17K
96523		<1%	292	$17K
95909		<1%	51	$17K
49083		<1%	19	$16K
93880		<1%	185	$16K
73200		<1%	52	$16K
82607		<1%	6,408	$16K
51798		<1%	712	$16K
72170		<1%	490	$16K
11750		<1%	85	$16K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	14,727	$16K
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	4,015	$16K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	17,703	$14K
87338		<1%	2,671	$14K
86850		<1%	9,903	$14K
76870		<1%	2,153	$14K
J0897	Injection, denosumab, 1 mg	<1%	26	$14K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	11,380	$14K
73521		<1%	451	$14K
29085		<1%	56	$13K
85027		<1%	22,095	$13K
97802		<1%	332	$12K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,030	$12K
87070		<1%	3,878	$12K
29105		<1%	39	$12K
92002		<1%	88	$11K
92585		<1%	44	$11K
A4648	Tissue marker, implantable, any type, each	<1%	203	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	44,390	$10K
88341		<1%	586	$10K
73660		<1%	620	$10K
99153	Mod sedat endo service >5yrs	<1%	1,074	$10K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	772	$9K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	43,161	$9K
72070		<1%	580	$9K
90715		<1%	10,134	$9K
J7318	Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg	<1%	31	$9K
76885		<1%	88	$9K
10022		<1%	12	$8K
84165		<1%	634	$8K
83970		<1%	1,349	$8K
95860		<1%	68	$8K
73100		<1%	81	$8K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,971	$8K
92134		<1%	4,148	$7K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	14,479	$7K
J2785	Injection, regadenoson, 0.1 mg	<1%	326	$7K
87186		<1%	12,794	$7K
83880		<1%	9,756	$7K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	1,168	$6K
82550		<1%	15,919	$6K
80164		<1%	975	$6K
83516		<1%	2,759	$6K
11730		<1%	26	$6K
91322		<1%	350	$6K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	109	$6K
97803		<1%	237	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,694	$6K
94761		<1%	2,111	$5K
82247		<1%	1,812	$5K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,258	$5K
95816		<1%	27	$5K
92567		<1%	5,317	$5K
84153		<1%	1,859	$5K
97535	Self-care/home management training, each 15 minutes	<1%	2,609	$5K
95910		<1%	12	$5K
86635		<1%	2,009	$5K
92523		<1%	117	$5K
11102		<1%	16	$4K
17250		<1%	15	$4K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,009	$4K
88312		<1%	3,680	$4K
A9270	Non-covered item or service	<1%	9,979	$4K
31500		<1%	40	$4K
82728		<1%	5,655	$4K
92950		<1%	45	$4K
97162		<1%	559	$4K
81001		<1%	99,646	$4K
A9585	Injection, gadobutrol, 0.1 ml	<1%	7,511	$4K
88304		<1%	3,316	$4K
84445		<1%	82	$4K
90686		<1%	2,772	$4K
84146		<1%	645	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	39,868	$4K
94618		<1%	214	$4K
73120		<1%	45	$3K
G0127	Trimming of dystrophic nails, any number	<1%	284	$3K
99442		<1%	302	$3K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	9,121	$3K
99223	Prolong inpt eval add15 m	<1%	42	$3K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	521	$3K
64400		<1%	59	$3K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	140	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	17,702	$3K
72190		<1%	18	$3K
82533		<1%	105	$3K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,414	$3K
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	8,018	$3K
76604		<1%	113	$3K
99360		<1%	2,541	$3K
73600		<1%	28	$3K
36591		<1%	959	$3K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,206	$3K
0450	Emergency room services	<1%	64	$3K
85730		<1%	6,487	$3K
88342		<1%	1,641	$3K
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	1,902	$3K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	761	$3K
82803		<1%	2,668	$2K
86704		<1%	1,847	$2K
90739		<1%	13	$2K
87045		<1%	380	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	14,929	$2K
83690		<1%	50,993	$2K
82570		<1%	14,126	$2K
84484		<1%	46,561	$2K
85610		<1%	52,614	$2K
76512		<1%	27	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,500	$2K
69210		<1%	72	$2K
90736		<1%	108	$2K
86331		<1%	926	$2K
11057		<1%	14	$2K
84030		<1%	355	$2K
83001		<1%	408	$2K
72146		<1%	13	$2K
84703		<1%	37,402	$2K
86708		<1%	1,570	$2K
62270		<1%	25	$2K
90662		<1%	1,712	$2K
T1019	Help at home with bathing, dressing and eating, billed per 15 minutes	<1%	587	$2K
86360		<1%	5,632	$2K
81025		<1%	26,483	$2K
70480		<1%	12	$2K
88112		<1%	1,508	$2K
73565		<1%	26	$2K
82950		<1%	989	$2K
90732		<1%	1,784	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	61,003	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,715	$2K
95861		<1%	14	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,353	$1K
29405		<1%	16	$1K
96376		<1%	17,030	$1K
77073		<1%	14	$1K
86141		<1%	9,699	$1K
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	3,667	$1K
96368		<1%	651	$1K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	360	$1K
82784		<1%	1,295	$1K
83655		<1%	587	$1K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	66,502	$1K
93242		<1%	20	$1K
73620		<1%	53	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	46,652	$1K
86592		<1%	9,758	$1K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	652	$1K
36415	Collection of venous blood by venipuncture	<1%	270,718	$1K
71101		<1%	43	$1K
70360		<1%	79	$978.74
0064A		<1%	297	$935.03
83735		<1%	19,515	$869.91
0134A		<1%	221	$867.14
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	20	$828.81
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	38	$822.80
86923		<1%	576	$811.73
90832	Psychotherapy session, about 30 minutes	<1%	16	$806.65
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	49,255	$795.70
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	23,302	$770.87
90837	Psychotherapy session, about an hour	<1%	23	$753.98
0004A		<1%	22	$751.22
95885		<1%	176	$733.94
87102		<1%	819	$733.93
84156		<1%	3,825	$728.04
86225		<1%	1,426	$719.29
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,320	$718.44
86706		<1%	2,483	$708.74
J2704	Injection, propofol, 10 mg	<1%	18,038	$708.12
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	225	$702.58
99205	Prolong outpt/office vis	<1%	13	$696.66
86703		<1%	46	$647.74
82105		<1%	1,177	$623.18
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	18	$613.72
93280		<1%	18	$608.05
86780		<1%	4,907	$603.23
97763		<1%	43	$599.02
83550		<1%	5,608	$577.02
J2270	Injection, morphine sulfate, up to 10 mg	<1%	24,863	$576.43
86255		<1%	177	$565.80
S5110	Home care training, family; per 15 minutes	<1%	60	$563.40
85379		<1%	6,188	$557.80
87077		<1%	12,782	$553.03
11720		<1%	15	$546.66
87486		<1%	1,317	$496.14
99441		<1%	98	$494.05
87040		<1%	14,370	$479.07
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	1,605	$477.36
99443		<1%	57	$465.75
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,110	$458.35
84439		<1%	7,776	$458.21
92133		<1%	1,522	$448.60
90750		<1%	284	$436.87
83605		<1%	14,874	$425.83
87210		<1%	9,938	$404.41
82150		<1%	396	$385.87
97164		<1%	205	$382.03
86039		<1%	88	$372.36
82140		<1%	2,307	$365.14
86901		<1%	13,479	$354.09
A6211	Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	13	$349.31
95012		<1%	155	$341.13
87177		<1%	60	$334.21
87517		<1%	100	$327.47
82652		<1%	100	$323.08
82565		<1%	1,653	$316.04
90834	Psychotherapy session, about 45 minutes	<1%	18	$311.22
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	202	$307.62
94644		<1%	2,099	$300.16
86900		<1%	13,480	$274.45
85055		<1%	4,899	$263.96
87116		<1%	572	$253.22
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	17,060	$253.05
83615		<1%	2,640	$253.00
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	53	$252.97
83921		<1%	120	$249.98
J1953	Injection, levetiracetam, 10 mg	<1%	1,091	$248.00
85007		<1%	21,665	$244.66
83993		<1%	27	$244.46
90656		<1%	225	$241.08
80069		<1%	44	$238.33
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	25	$217.07
86762		<1%	786	$214.41
88173		<1%	85	$208.52
J7030	Infusion, normal saline solution , 1000 cc	<1%	14,628	$207.50
G0008	Administration of influenza virus vaccine	<1%	8,795	$205.20
87449		<1%	2,148	$189.98
87430		<1%	3,929	$186.66
81003		<1%	9,807	$185.52
87150		<1%	402	$174.68
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,283	$174.08
87340		<1%	3,707	$170.38
83021		<1%	52	$169.32
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	480	$165.98
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	270	$153.89
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	32	$151.70
82010		<1%	1,541	$148.52
86431		<1%	1,711	$139.84
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	991	$137.91
86769		<1%	25	$134.83
92526		<1%	216	$132.98
80179		<1%	3,747	$131.77
80143		<1%	3,823	$131.77
84145		<1%	924	$131.02
87581		<1%	1,316	$130.00
82330		<1%	677	$128.48
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14,910	$122.77
82962		<1%	8,214	$117.12
84466		<1%	56	$117.09
87205		<1%	5,624	$115.77
97018		<1%	1,079	$114.77
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	12	$113.37
84550		<1%	2,486	$112.08
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,089	$110.00
84480		<1%	1,846	$109.38
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26,592	$109.38
87081		<1%	3,056	$100.80
80178		<1%	145	$95.60
88108		<1%	27	$93.42
L0172	Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf	<1%	1,133	$90.81
97166		<1%	51	$87.48
93325		<1%	37	$87.21
82378		<1%	25	$86.19
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	18,939	$85.91
87075		<1%	270	$85.38
A6258	Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	13,355	$85.22
86038		<1%	3,049	$83.98
87481		<1%	306	$80.72
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,453	$78.90
84460		<1%	879	$78.82
A4649	Surgical supply; miscellaneous	<1%	215	$76.95
87653		<1%	155	$76.67
J2060	Injection, lorazepam, 2 mg	<1%	7,556	$76.41
84100		<1%	9,638	$76.00
84481		<1%	977	$73.35
86160		<1%	1,761	$71.33
J1790	Injection, droperidol, up to 5 mg	<1%	1,836	$70.18
85652		<1%	10,069	$65.08
A6206	Contact layer, sterile, 16 sq. in. or less, each dressing	<1%	109	$62.73
83540		<1%	6,003	$62.57
84132		<1%	414	$62.14
97016		<1%	7,158	$61.95
J1815	Injection, insulin, per 5 units	<1%	7,392	$60.12
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	14,917	$57.78
86709		<1%	592	$55.45
J1630	Injection, haloperidol, up to 5 mg	<1%	4,644	$51.06
82670		<1%	283	$50.44
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	307	$49.42
77063	Screening digital breast tomosynthesis, bilateral	<1%	8,452	$47.52
82785		<1%	616	$45.05
Q0114	Fern test	<1%	1,780	$43.78
88300		<1%	562	$38.08
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	8,090	$37.18
85014		<1%	2,419	$34.27
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	7,905	$32.75
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,592	$32.50
J1940	Injection, furosemide, up to 20 mg	<1%	2,438	$31.38
82248		<1%	2,080	$30.88
94645		<1%	55	$30.80
82103		<1%	415	$30.63
82947		<1%	343	$28.27
J3480	Injection, potassium chloride, per 2 meq	<1%	1,958	$27.91
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,009	$26.47
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	3,224	$26.45
80047		<1%	1,062	$25.90
82043		<1%	11,497	$25.39
84295		<1%	106	$23.94
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,026	$23.66
94760		<1%	802	$23.26
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,715	$21.50
J1644	Injection, heparin sodium, per 1000 units	<1%	5,164	$21.23
C1729	Catheter, drainage	<1%	512	$20.12
G0379	Direct admission of patient for hospital observation care	<1%	516	$19.66
86359		<1%	5,632	$19.21
83002		<1%	188	$19.17
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,130	$18.96
36600		<1%	136	$18.16
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	10,516	$17.93
76937		<1%	249	$16.89
86256		<1%	125	$15.39
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,225	$14.84
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	4,313	$14.67
82390		<1%	367	$14.08
85384		<1%	136	$12.66
82977		<1%	610	$12.65
88740		<1%	446	$12.62
J0456	Injection, azithromycin, 500 mg	<1%	687	$11.96
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,386	$11.59
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	5,608	$11.25
G0009	Administration of pneumococcal vaccine	<1%	3,447	$11.19
90480		<1%	374	$11.02
J3411	Injection, thiamine hcl, 100 mg	<1%	1,510	$10.72
A6234	Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	286	$10.50
85046		<1%	643	$9.15
85018		<1%	194	$7.87
86593		<1%	1,513	$7.37
86308		<1%	98	$7.17
J3360	Injection, diazepam, up to 5 mg	<1%	366	$6.80
C9113	Injection, pantoprazole sodium, per vial	<1%	1,710	$6.77
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	313	$6.75
99152		<1%	1,458	$6.56
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	702	$6.46
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	622	$6.15
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	559	$5.99
90653		<1%	1,115	$5.45
84270		<1%	1,116	$5.12
J8540	Dexamethasone, oral, 0.25 mg	<1%	127	$5.12
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,420	$4.97
84300		<1%	562	$4.52
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	4,086	$3.16
86200		<1%	1,339	$2.71
89050		<1%	213	$1.52
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	177	$0.93
J2020	Injection, linezolid, 200 mg	0%	133	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	464	$0.00
87206		0%	434	$0.00
83930		0%	400	$0.00
J3535	Drug administered through a metered dose inhaler	0%	188	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	1,842	$0.00
82104		0%	139	$0.00
D0230	Intraoral - periapical each additional radiographic image	0%	296	$0.00
90674		0%	672	$0.00
96415		0%	786	$0.00
88307		0%	653	$0.00
G8983	Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting	0%	178	$0.00
76819	Fetal biophysical profile; without non-stress testing	0%	15	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	95	$0.00
89060		0%	387	$0.00
G8986	Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting	0%	2,384	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	472	$0.00
86376		0%	457	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	44	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	698	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	60	$0.00
D0120	Dental checkup, returning patient	0%	127	$0.00
V2632	Posterior chamber intraocular lens	0%	554	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	683	$0.00
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	0%	502	$0.00
80329		0%	6,349	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	426	$0.00
Q0222	Injection, bebtelovimab, 175 mg	0%	39	$0.00
90474		0%	168	$0.00
90697		0%	48	$0.00
A7521	Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each	0%	577	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	227	$0.00
90680		0%	160	$0.00
0346T		0%	371	$0.00
86364		0%	12	$0.00
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	0%	80	$0.00
97014		0%	623	$0.00
87593		0%	13	$0.00
84154		0%	12	$0.00
D0140	Limited oral evaluation - problem focused	0%	16	$0.00
D1206	Topical application of fluoride varnish	0%	188	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	287	$0.00
87046		0%	42	$0.00
82945		0%	38	$0.00
0012A		0%	63	$0.00
87015		0%	314	$0.00
82553		0%	341	$0.00
0011A		0%	71	$0.00
C1781	Mesh (implantable)	0%	28	$0.00
84157		0%	51	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	26	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	28	$0.00
80051		0%	92	$0.00
J1836	Injection, metronidazole, 10 mg	0%	441	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	604	$0.00
99406		0%	42	$0.00
0031A		0%	27	$0.00
87529		0%	29	$0.00
83935		0%	29	$0.00
29130		0%	12	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	42	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	15	$0.00
90723		0%	26	$0.00
86701		0%	13	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	59	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	30	$0.00
93320		0%	12	$0.00
90632		0%	14	$0.00
80177		0%	13	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	23	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	113	$0.00
96110	Developmental screening, with scoring and documentation, per standardized instrument	0%	12	$0.00
86702		0%	13	$0.00
82436		0%	14	$0.00
G0010	Administration of hepatitis b vaccine	0%	15	$0.00
97116		0%	861	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	1,397	$0.00
77061		0%	1,446	$0.00
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	0%	200	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	52	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	1,630	$0.00
76514		0%	44	$0.00
A4565	Slings	0%	2,593	$0.00
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	0%	279	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	1,570	$0.00
89051		0%	834	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	1,535	$0.00
84450		0%	860	$0.00
77062		0%	2,331	$0.00
93225		0%	712	$0.00
76981		0%	2,299	$0.00
84155		0%	287	$0.00
D1120	Dental cleaning, child	0%	213	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	128	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	298	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	1,886	$0.00
92025		0%	39	$0.00
A0110	Non-emergency transportation and bus, intra or inter state carrier	0%	105	$0.00
J7510	Prednisolone oral, per 5 mg	0%	375	$0.00
94729		0%	1,504	$0.00
88313		0%	50	$0.00
84520		0%	361	$0.00
D0220	Intraoral - periapical first radiographic image	0%	727	$0.00
86705		0%	105	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	2,261	$0.00
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	0%	111	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	251	$0.00
92611		0%	251	$0.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	0%	252	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	1,909	$0.00
85460		0%	57	$0.00
J7070	Infusion, d5w, 1000 cc	0%	217	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	76	$0.00
96417		0%	365	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	128	$0.00
86765		0%	47	$0.00
94770		0%	537	$0.00
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	0%	52	$0.00
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	0%	39	$0.00
90633		0%	39	$0.00
86015		0%	118	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	16	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	129	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	14	$0.00
A0160	Non-emergency transportation: per mile - case worker or social worker	0%	69	$0.00
87324		0%	105	$0.00
T2003	Non-emergency transportation, per trip	0%	63	$0.00
71100		0%	13	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	58	$0.00
86787		0%	31	$0.00
90648		0%	35	$0.00
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	0%	34	$0.00
Q0243	Injection, casirivimab and imdevimab, 2400 mg	0%	27	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	47	$0.00
84133		0%	43	$0.00
J3486	Injection, ziprasidone mesylate, 10 mg	0%	82	$0.00
86147		0%	12	$0.00
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	21	$0.00
90682		0%	44	$0.00
Q0239	Injection, bamlanivimab-xxxx, 700 mg	0%	40	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	58	$0.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	0%	15	$0.00
86735		0%	15	$0.00
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	0%	39	$0.00
85060		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFOWLER, PAMELA (SYSTEM DIRECTOR OF REIMBURSEMENT)

Same official

Other billing entities under FOWLER, PAMELA

Full network →

Provider	Location	Paid
Maricopa County Special Health Care District	Phoenix, AZ	$19.60M
Maricopa County Special Health Care District	Avondale, AZ	$18.89M
Maricopa County Special Health Care District	Chandler, AZ	$17.70M
Maricopa County Special Health Care District	Phoenix, AZ	$15.77M
Maricopa County Special Health Care District	Phoenix, AZ	$15.39M
Maricopa County Special Health Care District	Peoria, AZ	$9.69M
Maricopa County Special Heallth Care District	Mesa, AZ	$24K
Maricopa County Special Health Care District	Phoenix, AZ	$15K
Maricopa County Special Health Care District	Phoenix, AZ	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.